Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | ACHE | P22303 | 3/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.49 |
| ▸ | HPGD | P15428 | 4/20 | 0.49 |
| ▸ | GAA | P10253 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | GLA | P06280 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | ESR1 | P03372 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11332752 | 0.87 | ACHE (0.59) | L3MBTL1ACHEALOX15KMT2AHPGD | |
| SCHEMBL18124424 | 0.87 | L3MBTL1 (0.60) | L3MBTL1KMT2AHPGDGAAKDM4E | |
| SCHEMBL15558301 | 0.87 | ALOX15 (0.60) | L3MBTL1ACHEALOX15KMT2AHPGD | |
| SCHEMBL11714906 | 0.85 | L3MBTL1 (0.63) | L3MBTL1KMT2AHPGDGAAKDM4E | |
| SCHEMBL7533286 | 0.85 | ACHE (0.66) | L3MBTL1ACHEALOX15KMT2AHPGD | |
| SCHEMBL11714902 | 0.85 | L3MBTL1 (0.59) | L3MBTL1KMT2AHPGDGAAKDM4E | |
| SCHEMBL12751344 | 0.84 | ACHE (0.46) | L3MBTL1ACHEALOX15KMT2AHPGD | |
| SCHEMBL9236008 | 0.84 | L3MBTL1 (0.57) | L3MBTL1KMT2AHPGDGAAKDM4E | |
| SCHEMBL28428387 | 0.84 | ALOX15 (0.49) | L3MBTL1ACHEALOX15KMT2AHPGD | |
| SCHEMBL5841814 | 0.84 | L3MBTL1 (0.57) | L3MBTL1KMT2AHPGDGAAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3865480-B1 | HYDRAZINE DERIVATIVES | FMC CORP (US) | 2025-11-05 | — | — | EP | disclosed |
| CN-115197036-B | Method for performing anti-mahalanobis hydrogen carboxylation reaction on photocatalytic olefin compound and carbon dioxide | 中国科学院理化技术研究所 | 2024-01-23 | — | — | CN | disclosed |
| US-11770971-B2 | Esters containing aromatic groups as solvents for organic electronic formulations | MERCK PATENT GMBH (DE) | 2023-09-26 | — | — | US | disclosed |
| US-11770971-B2 | Esters containing aromatic groups as solvents for organic electronic formulations | MERCK PATENT GMBH (DE) | 2023-09-26 | — | — | US | disclosed |
| US-11770971-B2 | Esters containing aromatic groups as solvents for organic electronic formulations | MERCK PATENT GMBH (DE) | 2023-09-26 | — | — | US | disclosed |
| CN-111018790-B | Pyridazinone herbicides | FMC公司 | 2023-09-19 | — | — | CN | disclosed |
| EP-3552252-B1 | PREPARATION PROCESS FOR AN ELECTRONIC DEVICE | MERCK PATENT GMBH (DE) | 2023-05-17 | — | — | EP | disclosed |
| EP-3552252-B1 | PREPARATION PROCESS FOR AN ELECTRONIC DEVICE | MERCK PATENT GMBH (DE) | 2023-05-17 | — | — | EP | disclosed |
| EP-4084109-A1 | ESTERS CONTAINING AROMATIC GROUPS AS SOLVENTS FOR ORGANIC ELECTRONIC FORMULATIONS | Merck Patent GmbH (DE) | 2022-11-02 | — | — | EP | disclosed |
| CN-115197036-A | Method for carrying out anti-Ma hydrocarboxylation reaction on olefin compound and carbon dioxide by photocatalysis | 中国科学院理化技术研究所 | 2022-10-18 | — | — | CN | disclosed |
| US-20200066990-A1 | PREPARATION PROCESS FOR AN ELECTRONIC DEVICE | MERCK PATENT GMBH (DE) | 2020-02-27 | — | — | US | disclosed |
| CN-106458926-B | Pyridazinone herbicides | FMC公司 | 2020-01-03 | — | — | CN | disclosed |
| US-20190016712-A1 | PYRIDAZINONE HERBICIDES | FMC CORPORATION | 2019-01-17 | — | — | US | disclosed |
| US-10118917-B2 | Pyridazinone herbicides | FMC CORPORATION | 2018-11-06 | — | — | US | disclosed |
| EP-3137456-A1 | PYRIDAZINONE HERBICIDES | E. I. du Pont de Nemours and Company (US) | 2017-03-08 | — | — | EP | disclosed |
| US-20170050953-A1 | PYRIDAZINONE HERBICIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2017-02-23 | — | — | US | disclosed |
| CN-106458926-A | Pyridazinone herbicides | 杜邦公司 | 2017-02-22 | — | — | CN | disclosed |
| WO-2015168010-A1 | PYRIDAZINONE HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-11-05 | — | — | WO | disclosed |
| EP-1196436-A2 | PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE | Bristol-Myers Squibb Pharma Company (US) | 2002-04-17 | — | — | EP | disclosed |
| WO-2001002424-A2 | PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE | DU PONT PHARMACEUTICALS COMPANY (US) | 2001-01-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190016712-A1 | PYRIDAZINONE HERBICIDES | CBR3, NOX5, NR5A2 | L3MBTL1 2686/4885ACHE 428/4885ALOX15 2332/4885 |
| US-20170050953-A1 | PYRIDAZINONE HERBICIDES | CBR3, NOX5, NR5A2 | L3MBTL1 2686/4885ACHE 428/4885ALOX15 2332/4885 |
| US-10118917-B2 | Pyridazinone herbicides | CBR3, NOX5, NR5A2 | L3MBTL1 2686/4885ACHE 428/4885ALOX15 2332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.